Sanofi and MyoKardia end heart disease drug collaboration

3rd January 2019 Uncategorised 0

Bringing an end to a four-year partnership, Sanofi has terminated its agreement with MyoKardia to jointly develop small-molecule therapeutics, targeting genetic mutations associated with certain heart diseases.

More: Sanofi and MyoKardia end heart disease drug collaboration
Source: News